Risk-of-bias assessment using Cochrane's revised tool for randomized trials (RoB 2) was useful but challenging and resource-intensive: observations from a systematic review

被引:49
作者
Crocker, Thomas Frederick [1 ,6 ]
Lam, Natalie [1 ,4 ]
Jordao, Magda [1 ]
Brundle, Caroline [1 ]
Prescott, Matthew [1 ]
Forster, Anne [1 ]
Ensor, Joie [2 ,5 ]
Gladman, John [3 ]
Clegg, Andrew [1 ]
机构
[1] Univ Leeds, Bradford Teaching Hosp NHS Fdn Trust, Bradford Inst Hlth Res, Acad Unit Ageing & Stroke Res, Bradford, England
[2] Keele Univ, Ctr Prognosis Res, Keele Sch Med, Keele, Staffs, England
[3] Nottingham Univ Hosp NHS Trust, Univ Nottingham & Hlth Care Older People, Ctr Rehabil & Ageing Res, Acad Unit Injury Inflammat & Recovery Sci, Nottingham, England
[4] Univ York, Fac Sci, Dept Hlth Sci, Mental Hlth & Addict Res Grp, ARRC Bldg, York, England
[5] Univ Birmingham, Inst Appl Hlth Res, Coll Med & Dent Sci, Birmingham, England
[6] Bradford Royal Infirm, Bradford Inst Hlth Res, Duckworth Lane, Bradford BD9 6RJ, England
基金
美国国家卫生研究院;
关键词
RoB2; Risk of bias; Process duration; Research methods; Certainty assessment; Systematic reviews;
D O I
10.1016/j.jclinepi.2023.06.015
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: To report our experience using version 2 of the Cochrane risk-of-bias tool for randomized trials (RoB 2).Study Design and Setting: Two reviewers independently applied RoB 2 to results of interest in a large systematic review of complex interventions and reached consensus. We recorded the time taken, and noted and discussed our difficulties using the tool, and the resolutions we adopted. We explored the time taken with regression analysis and summarized our experience of implementing the tool.Results: We assessed risk of bias in 860 results of interest in 113 studies. Staff resource averaged 358 minutes per study (SD 183). Number of results (5 = 22) and reports (5 = 14) per study and experience of the team (5 = -6) significantly affected assessment time. To implement the tool consistently, we developed cut points for missingness and considerations of balance regarding missingness, assumed some concerns with intervention deviations unless otherwise prevented or investigated, some concerns with measurements from unblinded self-reporting participants, and judged low risk of selection for certain dichotomous outcomes despite the absence of an analysis plan.Conclusion: The RoB 2 tool and guidance are useful but resource-intensive and challenging to implement. Critical appraisal tools and reporting guidelines should detail risk of bias implementation. Improved guidance focusing on implementation could assist reviewers.& COPY; 2023 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativeco mmons.org/licenses/by/4.0/).
引用
收藏
页码:39 / 45
页数:7
相关论文
共 17 条
[1]  
[Anonymous], 2022, What works clearinghouse: Procedures and standards handbook
[2]  
Cochrane Training, ROB 2 LEARN LIV WEB
[3]  
Crocker TF, 2023, HEALTH TECHNOL ASSES
[4]   Community-based complex interventions to sustain independence in older people, stratified by frailty: a protocol for a systematic review and network meta-analysis [J].
Crocker, Thomas F. ;
Clegg, Andrew ;
Riley, Richard D. ;
Lam, Natalie ;
Bajpai, Ram ;
Jordao, Magda ;
Patetsini, Eleftheria ;
Ramiz, Ridha ;
Ensor, Joie ;
Forster, Anne ;
Gladman, John R. F. .
BMJ OPEN, 2021, 11 (02)
[5]  
Eldridge SM., 2021, Revised Cochrane risk of bias tool for randomized trials [RoB 2.0]: additional considerations for cluster-randomized trials
[6]   GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias) [J].
Guyatt, Gordon H. ;
Oxman, Andrew D. ;
Vist, Gunn ;
Kunz, Regina ;
Brozek, Jan ;
Alonso-Coello, Pablo ;
Montori, Victor ;
Akl, Elie A. ;
Djulbegovic, Ben ;
Falck-Ytter, Yngve ;
Norris, Susan L. ;
Williams, John W., Jr. ;
Atkins, David ;
Meerpohl, Joerg ;
Schuenemann, Holger J. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2011, 64 (04) :407-415
[7]  
Higgins J.P. T., 2019, Revised cochrane riskofbias tool for randomized trials (RoB2), DOI DOI 10.1136/BMJ.L4898
[8]  
Higgins JPT., COCHRANE HDB SYSTEMA
[9]   The Cochrane Collaboration's tool for assessing risk of bias in randomised trials [J].
Higgins, Julian P. T. ;
Altman, Douglas G. ;
Gotzsche, Peter C. ;
Jueni, Peter ;
Moher, David ;
Oxman, Andrew D. ;
Savovic, Jelena ;
Schulz, Kenneth F. ;
Weeks, Laura ;
Sterne, Jonathan A. C. .
BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
[10]   Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: Overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews [J].
Jørgensen L. ;
Paludan-Müller A.S. ;
Laursen D.R.T. ;
Savović J. ;
Boutron I. ;
Sterne J.A.C. ;
Higgins J.P.T. ;
Hróbjartsson A. .
Systematic Reviews, 5 (1)